Maeve Smith1, Eileen C O'Brien1, Goiuri Alberdi1, Aisling A Geraghty1, Mark Kilbane2, Malachi J McKenna3,4, Fionnuala M McAuliffe5. 1. UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland. 2. Departments of Clinical Chemistry, St Vincent's University Hospital, Dublin, Ireland. 3. Departments of Clinical Chemistry and Endocrinology, St Vincent's University Hospital, Dublin, Ireland. 4. School of Medicine, University College Dublin, Dublin, Ireland. 5. UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland. fionnuala.mcauliffe@ucd.ie.
Abstract
BACKGROUND: Vitamin D status may play a role in the development of atopic diseases due to its action on lung development and immune system development and function. AIMS: Our objective was to assess whether 25-hydroxyvitamin D (25OHD) levels in maternal blood in pregnancy were associated with atopy in children. METHODS: We analysed 279 mother-child pairs from the ROLO study conducted in Dublin, Ireland. Serum 25OHD was measured at 13 and 28 weeks of pregnancy. Development of childhood atopy was self-reported by mothers at follow-up appointments at 6 months, 2 years or 5 years. Logistic regression analysis was used to evaluate associations between maternal 25OHD status and development of atopy. RESULTS: The mean (SD) 25OHD levels in early and late pregnancy were 41.9 (19.2) nmol/L and 40.2 (21.6) nmol/L, respectively. Maternal 25OHD status in early pregnancy, but not in late pregnancy, was associated with a reduced risk of atopy at 2 years (OR 0.972, CI 0.946-0.999). In early pregnancy, those with serum 25OHD levels < 30 nmol/L compared with those with 25OHD > 50 nmol/L had significantly greater risk of developing atopy at 2 years (OR 4.76, CI 1.38-16.47). CONCLUSIONS: The development of childhood atopy may be associated with maternal vitamin D deficiency in early pregnancy among a cohort of women at risk of vitamin D deficiency. Further research is required to explore the relationship between vitamin D and atopy, particularly among women with poor vitamin D status, and whether supplementation should be prioritised in early pregnancy to reduce childhood atopy.
BACKGROUND:Vitamin D status may play a role in the development of atopic diseases due to its action on lung development and immune system development and function. AIMS: Our objective was to assess whether 25-hydroxyvitamin D (25OHD) levels in maternal blood in pregnancy were associated with atopy in children. METHODS: We analysed 279 mother-child pairs from the ROLO study conducted in Dublin, Ireland. Serum 25OHD was measured at 13 and 28 weeks of pregnancy. Development of childhood atopy was self-reported by mothers at follow-up appointments at 6 months, 2 years or 5 years. Logistic regression analysis was used to evaluate associations between maternal 25OHD status and development of atopy. RESULTS: The mean (SD) 25OHD levels in early and late pregnancy were 41.9 (19.2) nmol/L and 40.2 (21.6) nmol/L, respectively. Maternal 25OHD status in early pregnancy, but not in late pregnancy, was associated with a reduced risk of atopy at 2 years (OR 0.972, CI 0.946-0.999). In early pregnancy, those with serum 25OHD levels < 30 nmol/L compared with those with 25OHD > 50 nmol/L had significantly greater risk of developing atopy at 2 years (OR 4.76, CI 1.38-16.47). CONCLUSIONS: The development of childhood atopy may be associated with maternal vitamin D deficiency in early pregnancy among a cohort of women at risk of vitamin D deficiency. Further research is required to explore the relationship between vitamin D and atopy, particularly among women with poor vitamin D status, and whether supplementation should be prioritised in early pregnancy to reduce childhood atopy.
Entities:
Keywords:
Atopic disease; Childhood; Longitudinal study; Pregnancy; ROLO; Vitamin D
Authors: Jennifer M Walsh; Mark Kilbane; Ciara A McGowan; Malachi J McKenna; Fionnuala M McAuliffe Journal: Fertil Steril Date: 2012-10-03 Impact factor: 7.329
Authors: Graham Devereux; Augusto A Litonjua; Stephen W Turner; Leone C A Craig; Geraldine McNeill; Sheelagh Martindale; Peter J Helms; Anthony Seaton; Scott T Weiss Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: C R Gale; S M Robinson; N C Harvey; M K Javaid; B Jiang; C N Martyn; K M Godfrey; C Cooper Journal: Eur J Clin Nutr Date: 2007-02-21 Impact factor: 4.016
Authors: A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses Journal: J Clin Endocrinol Metab Date: 2010-11-29 Impact factor: 5.958
Authors: Debra Jane Palmer; Thomas R Sullivan; Clark M Skeaff; Lisa G Smithers; Maria Makrides Journal: World Allergy Organ J Date: 2015-10-06 Impact factor: 4.084
Authors: Bo L Chawes; Klaus Bønnelykke; Pia F Jensen; Ann-Marie M Schoos; Lene Heickendorff; Hans Bisgaard Journal: PLoS One Date: 2014-06-12 Impact factor: 3.240
Authors: Yih-Chieh S Chen; Hooman Mirzakhani; Mengdi Lu; Robert S Zeiger; George T O'Connor; Megan T Sandel; Leonard B Bacharier; Avraham Beigelman; Vincent J Carey; Benjamin J Harshfield; Nancy Laranjo; Augusto A Litonjua; Scott T Weiss; Kathleen A Lee-Sarwar Journal: J Allergy Clin Immunol Pract Date: 2021-06-21